Fundraising, Subscription by Directors and Love Hemp Q1 Trading Update

World High Life Plc (“World High Life” or the “Company”) (AQSE:LIFE) (OTCQB:WRHLF) announces that it has raised £566,206 via the issue of 56,620,600 ordinary shares of 1 pence each in the Company (“Ordinary Shares”; the “Subscription Shares”) at a subscription price of 1.0p per share. The proceeds of the Subscription Shares will be used by the Company for general working capital purposes


Subscribers for the Subscription Shares also received 1 share purchase warrant for every 1 Ordinary Share subscribed for, amounting in aggregate to 56,620,600 warrants (“Warrants“). The Warrants may be exercised at any time until 2 years from the closing of this financing at an exercise price of 1.0p per Ordinary Share.

Andrew Male and Robert Payment, Executive Directors of World High Life, subscribed for 4,000,000 and 350,000 Subscription Shares, respectively. Andrew Male is now interested in 4,709,625 Ordinary Shares, representing 1.6% of the Company’s issued share capital, and Robert Payment is now interested in 1,307,778 Ordinary Shares, representing 0.5% of the Company’s issued share capital.

Application has been made for the Subscription Shares to be admitted to trading on the AQSE Growth Market and admission is expected to become effective on 2 February 2021.

Following the issue of the Subscription Shares, the Company has 286,740,419 Ordinary Shares in issue, each share carrying the right to one vote. The figure of 286,740,419 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

In addition, the Directors are pleased to announce that Love Hemp Limited (“Love Hemp“), a wholly owned subsidiary of World High Life, achieved 1st quarter unaudited sales (1 July – 30 September 2020), of £793,500 ($1,070,000). These sales represent an increase of approximately 13% over the previous quarter.

The increase in sales represent a strong increase during the COVID 19 pandemic across all platforms: Love Hemp, CBDOilsUk.com, LH Life and wholesale activities, including LH Botanicals,” noted Tony Calamita, Love Hemp Founder and CEO. “Love Hemp has developed and strengthened a multi-platform brand strategy during the pandemic that we believe provides a launch pad for future growth”.

Q1 Highlights

  • Revenue up 13% compared to previous 3 months
  • Conversion rate up 12% compared to previous 3 months
  • Over 14,000 units sold online
  • Over 5,000 customer accounts created

The Directors of the Company accept responsibility for the contents of this announcement.

About Love Hemp

Love Hemp is one of the UK’s leading CBD and Hemp product suppliers and has more than 40 product lines, comprising oils, sprays and vapes and a variety of edible and water-based CBD products. Love Hemp has established relationships with over 1,200 stores in the UK, including leading brands such as Ocado, Holland & Barrett and WH Smith.

About World High Life

World High Life was established by the founders of Supreme Cannabis (TSX: FIRE), and 1933 Industries (CSE: TGIF), both companies at the forefront of the legalized cannabis industry. LIFE was established to take advantage of the huge opportunities available in the UK and European legal cannabis space, which is set to be the largest in the world within five years.

For further information please contact:

Andrew Male
Director
World High Life Plc
+44 (0) 7926 397 675
info@worldhighlife.uk

AQSE Corporate Adviser
Mark Anwyl/Allie Feuerlein
Peterhouse Capital Limited
+44 (0) 20 7469 0930
ma@peterhousecap.com
af@peterhousecap.com

For more information on World High Life please visit: www.worldhighlife.uk

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Andrew Male

2.

Reason for the notification

a)

Position/status:

Director

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

World High Life Plc

b)

LEI:

213800ERYVHIGFSPMM75

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of £0.01

GB00BK26FQ62

b)

Nature of the transaction:

Subscription of ordinary shares and grant of warrants

c)

Price(s) and volume(s):

Ordinary Shares:

Price(s)

Volume(s)

£0.01

4,000,000

Warrants:

Price(s)

Volume(s)

£0.01

4,000,000

d)

Aggregated information:

Aggregated volume:

Price:

Ordinary Shares:

Price(s)

Volume(s)

£0.01

4,000,000

Warrants:

Price(s)

Volume(s)

£0.01

4,000,000

e)

Date of the transaction:

2021-01-27

f)

Place of the transaction:

Off-market

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Robert Payment

2.

Reason for the notification

a)

Position/status:

Director

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

World High Life Plc

b)

LEI:

213800ERYVHIGFSPMM75

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of £0.01

GB00BK26FQ62

b)

Nature of the transaction:

Subscription of ordinary shares and grant of warrants

c)

Price(s) and volume(s):

Ordinary Shares:

Price(s)

Volume(s)

£0.01

350,000

Warrants:

Price(s)

Volume(s)

£0.01

350,000

d)

Aggregated information:

Aggregated volume:

Price:

Ordinary Shares:

Price(s)

Volume(s)

£0.01

350,000

Warrants:

Price(s)

Volume(s)

£0.01

350,000

e)

Date of the transaction:

2021-01-27

f)

Place of the transaction:

Off-market

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Cautionary Note Regarding Forward Looking Information

We seek safe harbour. Some statements contained in this news release are “forward looking information” within the meaning of securities laws. Forward looking information include, but are not limited to, statements regarding the use of proceeds of the non-brokered private placement and payment of the debt settlements. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, “believes” or variations of such words and phrases (including negative or grammatical variations) or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” or the negative connotation thereof. Investors are cautioned that forward-looking information is inherently uncertain and involves risks, assumptions and uncertainties that could cause actual results to differ materially. There can be no assurance that future developments affecting the Company will be those anticipated by management. The forward-looking information contained in this press release constitutes management’s current estimates, as of the date of this press release, with respect to the matters covered thereby. We expect that these estimates will change as new information is received. We do not undertake to update any estimate at any particular time or in response to any particular event, except as required by law.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: World High Life Plc

View source version on accesswire.com:
https://www.accesswire.com/626328/World-High-Life-PLC-Announces-Fundraising-Subscription-by-Directors-Q1-Update

News Provided by ACCESSWIRE via QuoteMedia

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less